Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
5.46
-0.01 (-0.18%)
Mar 4, 2026, 4:00 PM EST - Market closed

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Pharmaceuticals
251.00K33.49M4.93M2.00M-
Pharmaceuticals Growth
-99.25%579.21%146.30%--
Total
251.00K33.49M4.93M2.00M-
Total Growth
-99.25%579.21%146.30%--

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
United States
251.00K33.49M4.93M2.00M-
United States Growth
-99.25%579.21%146.30%--
Total
251.00K33.49M4.93M2.00M-
Total Growth
-99.25%579.21%146.30%--
Source: S&P Global Market Intelligence.